4月1日 - ** 生物技术公司Zymeworks ZYME.O股价盘前上涨2.6%至25.70美元
** 公司称任命克里斯汀-斯塔福德（Kristin Stafford）为首席财务官，立即生效
** Stafford曾在Royalty Pharma RPRX.O担任高级副总裁兼首席会计官。
** 她还曾在 BioPharma Credit 担任财务领导职务，并在安永会计师事务所为生命科学公司从事资本市场交易工作 - ZYME
** ZYME首席执行官肯尼斯-加尔布雷斯（Kenneth Galbraith）表示，斯塔福德的经验将有助于规范资本分配和创造长期价值。
** 截至上一交易日收盘，股价累计下跌约5%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.